Curculigoside attenuates cerebral ischemia-reperfusion injury via TRPM2-mediated microglial polarization
Human & Experimental Toxicology
Published online on February 26, 2026
Abstract
Human & Experimental Toxicology, Volume 45, January-December 2026.
ObjectiveCerebral ischemia-reperfusion injury (CIRI) remains a major challenge in clinical practice, without effective and targeted approaches to address it. Curculigoside has been reported to exert beneficial effects in CIRI, yet the underlying novel ...
ObjectiveCerebral ischemia-reperfusion injury (CIRI) remains a major challenge in clinical practice, without effective and targeted approaches to address it. Curculigoside has been reported to exert beneficial effects in CIRI, yet the underlying novel ...